Xinhua Li
NIH Rank #431
- Program Leader
- Top 5% Funded
- Early Career
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10741889Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2024
Linked Award Amount
$8.6M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#431
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Xinhua Li as a PI. Multi-PI records show the full award amount for context.
- 5U01DA058548-02U01Clinical Development of a Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication$4.1Maward amount
- 5UG3DA059286-02UG3A Therapeutic Agent to Lower the Level of Synthetic Opioids in the Body$3.1Maward amount
- 2R44DA056272-02R44A Novel Reversal Agent for Treatment of Overdose from the Combination of Fentanyl and Xylazine$1.5Maward amount
Award organization
Organizations that administered FY2024 awards listing Xinhua Li as a PI.
FY2024 award administered by Clear Scientific, LLC (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardClear Scientific, LLC
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #431
- 2024Entered Top 25% NationallyRanked #431
- 2024Entered Top 10% NationallyRanked #431
- 2024Entered Top 5% NationallyRanked #431
- 2025$10M Cumulative Funding